Arrhythmias, clinical electrophysiology, drugs

Citations 1-4 of 4 total displayed.

Most recent content (1 Sep 2009):

Original Articles
Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation

Amanda R. Patrick, Jerry Avorn, and Niteesh K. Choudhry
Circ Cardiovasc Qual Outcomes 2009;2:429-436; published online before print as doi:10.1161/CIRCOUTCOMES.108.808592 [Abstract] [Full text]  

Past content (since May 2009):

Original Articles
Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The ATRIA Study

Daniel E. Singer, Yuchiao Chang, Margaret C. Fang, Leila H. Borowsky, Niela K. Pomernacki, Natalia Udaltsova, and Alan S. Go
Circ Cardiovasc Qual Outcomes 2009;2:297-304; published online before print as doi:10.1161/CIRCOUTCOMES.108.830232 [Abstract] [Full text]  

Original Articles
Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease

Wayne A. Ray, Cristina Varas-Lorenzo, Cecilia P. Chung, Jordi Castellsague, Katherine T. Murray, C. Michael Stein, James R. Daugherty, Patrick G. Arbogast, and Luis A. García-Rodríguez
Circ Cardiovasc Qual Outcomes 2009;2:155-163; published online before print as doi:10.1161/CIRCOUTCOMES.108.805689 [Abstract] [Full text]  

Original Articles
New-Onset Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Graft Surgery and Long-Term Survival

Giovanni Filardo, Cody Hamilton, Robert F. Hebeler, Jr, Baron Hamman, and Paul Grayburn
Circ Cardiovasc Qual Outcomes 2009;2:164-169; published online before print as doi:10.1161/CIRCOUTCOMES.108.816843 [Abstract] [Full text]